Tuesday, 15 March 2011 20:36
Written by Blog Administrator
According to FDA and the Wall Street Journal, the FDA and the Department of Justice announced a consent decree to permanently enjoin Johnson & Johnson subsidiary McNeil-PPC Inc from the manufacture or distribution of products from its Fort Washington, Pa., plant until FDA determines the operations comply with federal law. In addition, the decree requires that Mcneil meet strict timetables in bringing its plants in Las Piedras, Puerto Rico, and Lancaster, Pa into compliance. The facilities manufacture both children and adult over the counter medications such as Motrin, Tylenol, Benadryl and Zyrtec. FDA contends that non-compliant manufacturing practices led to the recall of such products on April 30, 2010.
For the FDA news release see:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm246685.htm